Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial

1. The evolution of cellular-based immunotherapy in the treatment of gastric cancer: an overview of clinical trials

   Lang Wu, Jasur Rizaev, Khaled Fahmi Fawy +7

   МақолаCAR-T cell therapy researchClinical & Translational Oncology20261 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.000259

2. Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?

   Manh-Cuong Vo, Van-Dinh-Huan Tran, Van‐Tan Nguyen +5

   МақолаCAR-T cell therapy researchJournal of Hematology & Oncology20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.000083